Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year

E-ISSN： 1600-6143|15|5|1293-1302

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.5, 2015-05, pp. : 1293-1302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of a Negative Conversion Trial and Subsequent Living Donor Kidney Transplant Outcome in Recipients with a Positive Lymphocyte Crossmatch

Nephron Clin Pract, Vol. 111, Iss. 1, 2008-12 ,pp. : c49-c54

Karger

Access to resources Recommend Favorite

Concerns of ABO incompatible and crossmatch‐positive potential donors and recipients about participating in kidney exchanges

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 3, 2015-03 ,pp. : 233-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of medication non‐adherence and associated outcomes in pediatric kidney transplant recipients

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 5, 2015-08 ,pp. : 555-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pretransplant virtual PRA and long‐term outcomes of kidney transplant recipients

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 6, 2015-06 ,pp. : 710-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does belatacept improve outcomes for kidney transplant recipients? A systematic review

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1251-1264

John Wiley & Sons Inc

Access to resources Recommend Favorite